Treatment of neoplasms with viruses
CA 2370187 C · Owner: Rabin, Harvey · Inventors: Von Borstel, Reid W.; Lorence, Robert M.; Roberts, Michael S.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The subject invention relates to viruses that are able to replicate and thereby kill neoplastic cells with a deficiency in the IFN-mediated antiviral response, and their use in treating neoplastic disease including cancer and large tumors. RNA and DNA viruses are useful in this regard. The invention also relates to methods for the selection design, purification and use of , such viruses for cancer therapy.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 17, 2000 and granted August 2, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 17, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 17, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.